New: A brand-new, unused, unopened and undamaged item in original retail packaging (where packaging is ... Read moreabout the condition
- Reebok 12K Youth Shoulder Pads
- shoes escursioni di mercato Regatta Holcombe grey medio lady 22928 - Nuovo
- RARE NIW 2014 DEMARINI FLIPPER AFTERMATH USA Border Battle 34 26 WTFXFLA ASA
- CWC 3-Strand Poly Dacron Rope - 9 16 x 600 ft., White w tracers
- Harkila Thyra Lady fleece X-Large X-Large
- Five Ten Anasazi VCS UK8
- Camping Table in Aluminium and MDF Case Shaped with Carry Handle Steel Frame cm
- Busch + Müller Ixon Core Led Front Light with Stvzo-Zulassung New
- 299 bowling ring , united states bowling congress. Size 12 1 2 ABC
- 2019 Gul Response Womens FX 3 2mm GBS Muta blue righe RE1264-B4
- Gul Response Adult 42 Bodyboard in Light blueee Unisex Surfing Surfer Gifts For
- SWEDEN SVERIGE 1980s 90s BASKETBALL JERSEY SIZE XL ADIDAS TRIKOT VINTAGE (j894)
- ATLANTA BRAVES JONES MAJESTIC 40TH ANNIVERSARY MAGLIA SHIRT JERSEY MLB BASEBALL
- Onyx Movevent Torsion X-Large 2Xl Red
- ADIDAS PREDATOR ABSOLION LZ TRX SG 39 40.5 NEW leathal zone adizero f50 f30
- Dc Richter Boa Snowboard Stiefel, Weiß
University of Iowa Stead Family Children’s Hospital is designed as a healing environment that improves the health and well-being of children and their families. Plans include expanding existing programs and developing new services on-site and throughout Iowa to meet the current and future needs of Iowa’s children.
University of Iowa Stead Family Children’s Hospital joins a group of more than 30 sites across the country committed to using research and education to help prevent injury to children.
Join us on Friday, July 12 at University of Iowa Health Care - Iowa River Landing for a bike safety event geared to the whole family.
Edward Bell, MD, a neonatologist at University of Iowa Stead Family Children’s Hospital, has been awarded the Maureen Andrew Mentor Award from the Society of Pediatric Research, following his 40 years in pediatric medicine.
UI researchers led by Miles Pufall, PhD, have identified a new target that may help improve treatment for children with relapsed B-cell acute lymphoblastic leukemia (B-ALL), the most common type of childhood cancer.